Previous research has suggested that triterpenoids induced by ROS inhibit rhabdomyosarcoma cells and tumor growth by targeting Sp transcription factors (Sp1, Sp3, Sp4)42. This evidence concerns the gene TFF2 and rhabdomyosarcoma.